Pacira BioSciences Reaches Analyst Target Price
January 08, 2021 at 09:00 AM EST
In recent trading, shares of Pacira BioSciences Inc (PCRX) have crossed above the average analyst 12-month target price of $66.90, changing hands for $67.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..